Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-21-067954

SVP, Chief Business Officer sold 499 shares at $6.69 ($3,338)

From the SEC's structured data for this filing

Trades in this filing

Mitchener Stephen · SVP, Chief Business Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-12-02 Sale : show line 1 in the form −499 $6.69 $3,338 3,296 D
Open-market sales · 499 sh · avg $6.69 · $3,338
Loading xslF345X03/doc4.xml…